GlassScriptPhysician profile
Anna Janet P Trejo
NPI 1104474980
$807.38
in general payments reported to CMS, 2019-2025
7 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.05 · 2024: $321 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.34 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $310.40 | 2025 | |
| Boston Scientific Corporation | $194.85 | 2024-2025 | General - Pain Management |
| Edwards Lifesciences Corporation | $139.51 | 2024 | Sapien 3 Ultra Resilia |
| Acadia Pharmaceuticals INC | $102.40 | 2025 | Nuplazid |
| Amarin Pharma, INC. | $24.31 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.74 | 2021 | |
| Glaxosmithkline, LLC. | $17.17 | 2024 | Rotarix, Bexsero, Pediarix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Janet Trejo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.